Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality?
Early reports from China found that both established cardiovascular disease and its risk factors, such as hypertension and diabetes mellitus, were common pre-existing conditions in patients with COVID- 19. The high prevalence of these comorbidities was confirmed in subsequent studies. Remarkably, th...
Autor principal: | |
---|---|
Formato: | Articulo Contribucion a revista |
Lenguaje: | Inglés |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/118998 |
Aporte de: |
id |
I19-R120-10915-118998 |
---|---|
record_format |
dspace |
institution |
Universidad Nacional de La Plata |
institution_str |
I-19 |
repository_str |
R-120 |
collection |
SEDICI (UNLP) |
language |
Inglés |
topic |
Ciencias Médicas COVID- 19 Hypertension |
spellingShingle |
Ciencias Médicas COVID- 19 Hypertension Salazar, Martín R. Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? |
topic_facet |
Ciencias Médicas COVID- 19 Hypertension |
description |
Early reports from China found that both established cardiovascular disease and its risk factors, such as hypertension and diabetes mellitus, were common pre-existing conditions in patients with COVID- 19. The high prevalence of these comorbidities was confirmed in subsequent studies. Remarkably, the prevalence of these pre-existing conditions was higher in critically ill patients and in those who died. In the analysis performed by Wu and McGoogan, including 44 672 patients with confirmed COVID-19, the overall case fatality rate was 2.3%, and increased with comorbid conditions: 10.5% for cardiovascular disease, 7.3% for diabetes, and 6% for hypertension. The connections between cardiovascular disease, hypertension, age, and vascular aging are complex. The association between hypertension and COVID-19 mortality or severity could be explained in part by the increased age and higher prevalence of cardiovascular disease, both well-known risk factors for mortality in critical patients.
Therefore, in order to identify independent predictors of COVID-19 mortality or severity, models should be properly adjusted to exclude potential confounding effects. |
format |
Articulo Contribucion a revista |
author |
Salazar, Martín R. |
author_facet |
Salazar, Martín R. |
author_sort |
Salazar, Martín R. |
title |
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? |
title_short |
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? |
title_full |
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? |
title_fullStr |
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? |
title_full_unstemmed |
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? |
title_sort |
is hypertension without any other comorbidities an independent predictor for covid-19 severity and mortality? |
publishDate |
2020 |
url |
http://sedici.unlp.edu.ar/handle/10915/118998 |
work_keys_str_mv |
AT salazarmartinr ishypertensionwithoutanyothercomorbiditiesanindependentpredictorforcovid19severityandmortality |
bdutipo_str |
Repositorios |
_version_ |
1764820447796396033 |